| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.07B | 37.80B | 41.82B | 21.04B | 16.44B | 10.58B |
| Gross Profit | 5.41B | 7.69B | 5.65B | 3.56B | 2.21B | 1.55B |
| EBITDA | 2.69B | 2.86B | 2.01B | 1.04B | 609.73M | 372.49M |
| Net Income | 938.46M | 1.94B | 1.35B | 647.57M | 336.17M | 172.42M |
Balance Sheet | ||||||
| Total Assets | 51.11B | 44.26B | 52.94B | 35.75B | 21.49B | 10.93B |
| Cash, Cash Equivalents and Short-Term Investments | 17.95B | 18.63B | 19.21B | 9.54B | 7.55B | 1.99B |
| Total Debt | 5.35B | 8.69B | 4.76B | 5.94B | 3.03B | 1.18B |
| Total Liabilities | 45.80B | 32.79B | 47.66B | 31.94B | 18.38B | 9.88B |
| Stockholders Equity | 5.32B | 11.47B | 5.27B | 3.81B | 3.11B | 1.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.28B | 10.96B | -1.26B | 1.27B | 196.17M |
| Operating Cash Flow | 0.00 | -8.21B | 10.02B | -1.21B | 1.29B | 274.83M |
| Investing Cash Flow | 0.00 | -676.10M | -1.17B | -134.78M | -122.80M | 237.44M |
| Financing Cash Flow | 0.00 | 8.08B | -1.11B | 2.91B | 3.57B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.17B | 11.62 | 17.21% | 4.27% | 13.39% | 22.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ¥16.66B | 8.91 | ― | 2.86% | 18.85% | 52.87% | |
51 Neutral | ¥18.32B | 11.57 | ― | 0.66% | -9.63% | 33.04% | |
50 Neutral | ¥7.29B | 59.14 | ― | 0.96% | -30.95% | -114.16% | |
43 Neutral | ¥15.34B | -11.91 | ― | ― | 180.01% | 33.62% |